Physician profile
Brian P Tiu
NPI 1902190226
$6,277.38
in general payments reported to CMS, 2019-2025
27 companies · $539 in 2025
The $539 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $98.22 · 2021: $470 · 2022: $1,920 · 2023: $991 · 2024: $1,152 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430 · Travel and Lodging: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,430.39 |
| Travel and Lodging | $251.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,371.38 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Angiodynamics, INC. | $1,223.68 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Veryan Medical Incorporated | $357.90 | 2022-2023 | Biomimics 3d Vascular Stent System |
| Cardiovascular Systems INC. | $290.60 | 2019-2022 | |
| Boston Scientific Corporation | $241.46 | 2019-2025 | Enroute Transcarotid Stent, Ranger |
| Medtronic, INC. | $214.13 | 2021-2025 | Endurant Iis, Eea |
| Shockwave Medical, INC | $205.71 | 2022-2025 | |
| Inari Medical, INC. | $197.03 | 2022 | |
| Cordis US Corp. | $147.90 | 2021-2023 | S.M.A.R.T. Control |
| Cagent Vascular INC | $142.64 | 2023 | Serrantor |
| Cumberland Pharmaceuticals, INC. | $125.60 | 2021 | |
| Vital Orthopedics LLC | $115.94 | 2025 | |
| Abbott Laboratories | $112.17 | 2024 | Esprit, Jeti All In One Non-Sterile Kit |
| Innocoll Pharmaceuticals Limited | $88.23 | 2022 | |
| Argon Medical Devices, INC. | $83.36 | 2023-2024 | Cleaner, Clot Management |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $72.16 | 2019 | |
| Cvrx, INC. | $57.66 | 2022-2025 | Barostim Neo System |
| Lemaitre Vascular, INC. | $37.83 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Stryker Corporation | $36.11 | 2025 | Limflow System |
| Artivion, INC. | $26.37 | 2024 | Bioglue Surgical Adhesive, Vascular, Photofix Decellularized Bovine Pericardium |
| Endologix LLC | $22.94 | 2025 | Endocross Device, Torus Stent Graft System |
| Glaxosmithkline, LLC. | $22.53 | 2021 | |
| Integra Lifesciences Corporation | $22.06 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cook Medical LLC | $20.60 | 2019 | |
| Terumo Medical Corporation | $19.93 | 2021 | |
| Tela Bio, INC. | $14.12 | 2019 | |
| Venclose INC. | $7.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.